Loading provider…
Loading provider…
Neurology Physician in Bloomington, IL
NPI: 1326233271Primary Practice Location
The Center for Outpatient Medicine
2502 East Empire Street, Bloomington, IL
Primary Employer
Christie Clinic, PLLC
christieclinic.com
HQ Phone
Get MD Barry's Phone NumberMobile
Get MD Barry's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 329 | 712 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 220 | 220 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 149 | 166 |
| 4 | 82746Folic acid level, serum | 134 | 134 |
| 5 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 134 | 200 |
Authors: Learmonth, Yvonne C, Adamson, Brynn C, Balto, Julia M, Chiu, Chung-Yi, Molina-Guzman, Isabel M, Finlayson, Marcia, Riskin, Barry J, Motl, Robert W
Journal: Health Expect
Publication Date: 2017-05-18
Authors: Sandroff, Brian M, Riskin, Barry J, Agiovlasitis, Stamatis, Motl, Robert W
Journal: J Neurol Sci
Publication Date: 2014-02-28
Accuracy of StepWatch™ and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis.
Authors: Brian Sandroff, Robert Motl, Lara Pilutti, Yvonne Learmonth, Ipek Ensari, Deirdre Dlugonski, Rachel Klaren, Swathi Balantrapu, Barry Riskin
Publication Date: 2013-09-04
Lead Sponsor: Satsuma Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebos, DRUG: Dihydroergotamine
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Galcanezumab